Tuesday, November 21, 2017

Miraca Life Sciences Acquired By Avista Capital

Irving, Texas-based Miraca Life Sciences, which operates an anatomic pathology laboratory, has been acquired by private equity investor Avista Capital Partners. Financial terms of the acquisition were not announced. Miraca Life Sciences provides anatomic pathology services in the fields of gastroenterology, dermatology, hematology, breast health, and urology. As part of the acquisition, Vista said it has appointed Scott Walton as CEO of Miraca Life Sciences; Walton was most recently President and CEO of Ameritox.